Altaf A. Dar

3.4k total citations
51 papers, 2.5k citations indexed

About

Altaf A. Dar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Altaf A. Dar has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 30 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Altaf A. Dar's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Altaf A. Dar is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Altaf A. Dar collaborates with scholars based in United States, Germany and Australia. Altaf A. Dar's co-authors include Shahana Majid, Rajvir Dahiya, Sharanjot Saini, Wael El‐Rifai, Soichiro Yamamura, Yuichiro Tanaka, Guoren Deng, Mohammed Kashani–Sabet, Mehdi Nosrati and Varahram Shahryari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Altaf A. Dar

50 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Altaf A. Dar United States 27 2.0k 1.2k 622 325 239 51 2.5k
Zhengsheng Wu China 27 1.5k 0.8× 953 0.8× 683 1.1× 240 0.7× 185 0.8× 69 2.3k
Aleksandra Franovic United States 18 1.3k 0.6× 744 0.6× 600 1.0× 289 0.9× 336 1.4× 38 2.0k
Song He China 30 1.5k 0.8× 593 0.5× 586 0.9× 223 0.7× 182 0.8× 93 2.1k
Mingxia Yan China 20 1.9k 1.0× 1.4k 1.1× 945 1.5× 168 0.5× 180 0.8× 37 2.7k
Dongwang Yan China 27 1.8k 0.9× 1.3k 1.0× 458 0.7× 103 0.3× 205 0.9× 48 2.3k
Kwan Man Hong Kong 17 1.7k 0.8× 1.3k 1.0× 743 1.2× 219 0.7× 138 0.6× 24 2.5k
Joyce Man‐Fong Lee Hong Kong 27 3.0k 1.6× 2.0k 1.6× 594 1.0× 150 0.5× 269 1.1× 42 3.9k
Gianmarco Contino Italy 16 1.6k 0.8× 667 0.5× 837 1.3× 215 0.7× 253 1.1× 26 2.7k
Jung-Sik Kim United States 26 1.5k 0.8× 406 0.3× 596 1.0× 232 0.7× 313 1.3× 45 2.2k
Nijiro Nohata Japan 39 3.1k 1.6× 2.6k 2.1× 393 0.6× 165 0.5× 312 1.3× 62 3.7k

Countries citing papers authored by Altaf A. Dar

Since Specialization
Citations

This map shows the geographic impact of Altaf A. Dar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Altaf A. Dar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Altaf A. Dar more than expected).

Fields of papers citing papers by Altaf A. Dar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Altaf A. Dar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Altaf A. Dar. The network helps show where Altaf A. Dar may publish in the future.

Co-authorship network of co-authors of Altaf A. Dar

This figure shows the co-authorship network connecting the top 25 collaborators of Altaf A. Dar. A scholar is included among the top collaborators of Altaf A. Dar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Altaf A. Dar. Altaf A. Dar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bezrookove, Vladimir, Imran Khan, Anukana Bhattacharjee, et al.. (2024). miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK. Journal of Translational Medicine. 22(1). 758–758. 1 indexed citations
2.
Semir, David de, Vladimir Bezrookove, Mehdi Nosrati, et al.. (2021). Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility. Cancer Research. 81(11). 2956–2969. 12 indexed citations
3.
Semir, David de, Vladimir Bezrookove, Mehdi Nosrati, et al.. (2018). PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer. Proceedings of the National Academy of Sciences. 115(25). E5766–E5775. 16 indexed citations
4.
Bezrookove, Vladimir, Mehdi Nosrati, James R. Miller, et al.. (2018). Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma. Clinical Cancer Research. 24(17). 4119–4125. 10 indexed citations
5.
Bhat, Nadeem S., Altaf A. Dar, Sharanjot Saini, et al.. (2017). MicroRNA-720 Regulates E-cadherin–αE-catenin Complex and Promotes Renal Cell Carcinoma. Molecular Cancer Therapeutics. 16(12). 2840–2848. 27 indexed citations
6.
Dar, Altaf A., Sharanjot Saini, Varahram Shahryari, et al.. (2017). MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death and Disease. 8(1). e2572–e2572. 107 indexed citations
7.
Shahryari, Varahram, Sharanjot Saini, Altaf A. Dar, et al.. (2016). Pre-clinical Orthotopic Murine Model of Human Prostate Cancer. Journal of Visualized Experiments. 9 indexed citations
8.
Zhou, Wen, Mehdi Nosrati, Shahana Majid, et al.. (2014). Antitumor Activity of miR-1280 in Melanoma by Regulation of Src. Molecular Therapy. 23(1). 71–78. 21 indexed citations
9.
Dar, Altaf A., Shahana Majid, David de Semir, et al.. (2013). The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression. JNCI Journal of the National Cancer Institute. 105(6). 433–442. 92 indexed citations
10.
Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2012). miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways. Clinical Cancer Research. 19(1). 73–84. 96 indexed citations
11.
Semir, David de, Mehdi Nosrati, Vladimir Bezrookove, et al.. (2012). Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Proceedings of the National Academy of Sciences. 109(18). 7067–7072. 30 indexed citations
12.
Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2012). miR-23b Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in Prostate Cancer. Cancer Research. 72(24). 6435–6446. 125 indexed citations
13.
Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2012). MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer. PLoS ONE. 7(10). e46743–e46743. 54 indexed citations
14.
Majid, Shahana, Sharanjot Saini, Altaf A. Dar, et al.. (2011). MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer. Cancer Research. 71(7). 2611–2621. 120 indexed citations
15.
Dar, Altaf A., Shahana Majid, David de Semir, et al.. (2011). miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein. Journal of Biological Chemistry. 286(19). 16606–16614. 202 indexed citations
16.
Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2010). Regulation of Minichromosome Maintenance Gene Family by MicroRNA-1296 and Genistein in Prostate Cancer. Cancer Research. 70(7). 2809–2818. 117 indexed citations
17.
Dar, Altaf A., Shahana Majid, Mehdi Nosrati, et al.. (2010). Functional Modulation of IGF-Binding Protein-3 Expression in Melanoma. Journal of Investigative Dermatology. 130(8). 2071–2079. 26 indexed citations
18.
Torabian, Sima, David de Semir, Mehdi Nosrati, et al.. (2009). Ribozyme-Mediated Targeting of IκBγ Inhibits Melanoma Invasion and Metastasis. American Journal Of Pathology. 174(3). 1009–1016. 8 indexed citations
19.
Belkhiri, Abbes, Altaf A. Dar, Dunfa Peng, et al.. (2008). Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells. Clinical Cancer Research. 14(14). 4564–4571. 37 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengsheng Wu Breakdown of academic impact, for papers by Aleksandra Franovic Breakdown of academic impact, for papers by Song He Breakdown of academic impact, for papers by Mingxia Yan Breakdown of academic impact, for papers by Dongwang Yan Breakdown of academic impact, for papers by Kwan Man Breakdown of academic impact, for papers by Joyce Man‐Fong Lee Breakdown of academic impact, for papers by Gianmarco Contino Breakdown of academic impact, for papers by Jung-Sik Kim Breakdown of academic impact, for papers by Nijiro Nohata
Rankless by CCL
2026